Growth Hormone Axis · Recombinant somatropin · Prescription
HGH 191AA: recombinant human growth hormone.
HGH 191AA — also called somatropin — is recombinant human growth hormone produced in E. coli with the exact 191-amino-acid sequence of native pituitary GH. It is the direct hormone itself rather than a secretagogue, and it carries a stricter regulatory and safety profile than GHRH analogs like sermorelin or CJC-1295.
What HGH 191AA is
HGH 191AA is recombinant human growth hormone — the same 191-amino-acid polypeptide that the anterior pituitary normally secretes, manufactured by recombinant DNA technology in bacterial cells.
Unlike GHRH analogs (sermorelin, CJC-1295, tesamorelin) which stimulate the pituitary to release endogenous GH, somatropin is the hormone itself. It bypasses the pituitary entirely.
It is FDA-approved for specific indications — pediatric growth failure, adult GH deficiency, AIDS-wasting, short-bowel syndrome, Turner syndrome — and is regulated under DEA scrutiny. It is not legal to prescribe for anti-aging or athletic performance.
How it works
Somatropin binds the GH receptor on hepatocytes and peripheral tissues, activating JAK2/STAT5 signaling. The dominant downstream output is IGF-1 production from the liver.
IGF-1 mediates most of GH's anabolic effects: muscle protein synthesis, chondrocyte proliferation (growth plate, cartilage), lipolysis in adipose tissue, and nitrogen retention.
GH itself has direct effects too — acutely raising free fatty acids, modulating glucose metabolism (mildly diabetogenic), and supporting collagen synthesis in connective tissue.
What patients use it for
Direct GH elevation
Bypasses pituitary capacity entirely — useful when somatotrophs cannot respond to GHRH analogs (true GH deficiency).
Body composition (in deficiency)
In documented adult GH deficiency, somatropin reliably reduces visceral fat and increases lean mass.
Bone density
In adult GH deficiency, restores GH-axis support of bone remodeling and BMD.
Predictable IGF-1 control
Dose-titrated against IGF-1 labs, allowing tighter physiologic control than secretagogues in select cases.
Evidence summary
Molitch ME et al. (JCEM, 2011) — Endocrine Society Clinical Practice Guideline for evaluation and treatment of adult GH deficiency.
Liu H et al. (Annals of Internal Medicine, 2007) systematic review of GH in healthy older adults found small body-composition changes with notable adverse-event burden.
Cohen P et al. (J Clin Endocrinol Metab, 2008) — consensus statement on pediatric GH use.
FDA approval history (Humatrope, Genotropin, Norditropin) provides extensive Phase III safety and efficacy data in approved indications.
Dosing and clinical context
General clinical context only. Kindr Health physicians determine the appropriate dose and protocol for each patient based on history and labs. This is not a prescription or dosing recommendation.
Subcutaneous injection, typically daily, dosed to a target IGF-1 level rather than fixed mg.
Adult-deficiency dosing is substantially lower than pediatric dosing.
Use outside approved indications is illegal under U.S. federal law (21 USC § 333(e)) — kindr only prescribes in documented adult GH deficiency or specific FDA-approved indications.
Safety and contraindications
Common: fluid retention, joint stiffness, carpal-tunnel symptoms, insulin resistance — typically dose-dependent and reversible.
Strict contraindications: active malignancy, proliferative diabetic retinopathy, critical illness, Prader-Willi with severe obesity.
Periodic IGF-1, fasting glucose, HbA1c, and clinical-symptom monitoring is mandatory.
Sale and distribution outside approved indications is a federal offense; we will not prescribe somatropin for anti-aging, athletic performance, or bodybuilding purposes.
Who it's typically considered for
- Adults with documented adult-onset GH deficiency confirmed by stimulation testing
- Patients with specific FDA-approved indications (AIDS wasting, short-bowel, Turner)
- Patients in whom GHRH-analog approaches (sermorelin, CJC-1295) have failed to produce adequate IGF-1 response
Frequently asked questions
HGH 191AA vs sermorelin / CJC-1295?
Somatropin is the hormone itself; secretagogues stimulate the pituitary to release endogenous GH. Secretagogues are gentler, preserve negative feedback, and have a much lighter regulatory profile. Most midlife patients are better served by secretagogues.
Can I get HGH for anti-aging?
No. U.S. federal law restricts somatropin to specific approved indications. kindr does not prescribe HGH for anti-aging or performance — but we do offer GHRH-analog protocols (sermorelin, CJC-1295 No DAC, tesamorelin) for midlife GH-axis support.
Is HGH 191AA legal?
Legal when prescribed for FDA-approved indications by a physician. Illegal when prescribed, dispensed, distributed, or used for anti-aging or performance enhancement.
What is the 192AA version?
An older, partially-deactivated synthetic GH with an extra methionine. The 191AA recombinant form is bioidentical to native pituitary GH and is the modern standard.
Will HGH make me look younger?
In documented deficiency, body composition and skin quality improve. In adults with normal GH, supraphysiologic exposure causes more side effects than benefits per the published literature.
How is dosing determined?
By target IGF-1 level in the upper-half of the age-appropriate reference range, titrated up from a low starting dose with monthly labs.
Sources
- Molitch ME et al. Evaluation and treatment of adult growth hormone deficiency: Endocrine Society Clinical Practice Guideline. JCEM (2011). — pubmed.ncbi.nlm.nih.gov/21646368
- Liu H et al. Systematic review: the safety and efficacy of GH in the healthy elderly. Ann Intern Med (2007). — pubmed.ncbi.nlm.nih.gov/17227932
- 21 USC § 333(e) — Federal restrictions on human growth hormone distribution. — www.law.cornell.edu/uscode/text/21/333
Considering HGH 191AA?
A Kindr Health physician reviews every longevity intake — peptides are prescribed only when medically indicated based on your history and labs. There is no charge for the initial review.
Start your longevity intake →Related peptides
Medically reviewed by Dr. Ana Lisa Carr, MD, MBA
Board-Certified Family Medicine Physician · Lead Provider / Medical Reviewer
NPI 1689841744 · Last reviewed: May 10, 2026
Last reviewed May 10, 2026. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products. Prescriptions require a clinical evaluation; a Kindr Health physician determines eligibility. Not for use in pregnancy. This page provides educational information and is not medical advice.